Cargando…

Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria

BACKGROUND: Plasmodium vivax occurs as a latent infection of liver and a patent infection of red blood cells. Radical cure requires both blood schizontocidal and hypnozoitocidal chemotherapies. The hypnozoitocidal therapies available are primaquine and tafenoquine, 8-aminoquinoline drugs that can pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Satyagraha, Ari Winasti, Sadhewa, Arkasha, Panggalo, Lydia Visita, Subekti, Decy, Elyazar, Iqbal, Soebianto, Saraswati, Mahpud, Nunung, Harahap, Alida Rosita, Baird, J. Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318249/ https://www.ncbi.nlm.nih.gov/pubmed/34270547 http://dx.doi.org/10.1371/journal.pntd.0009610

Ejemplares similares

G6PD Deficiency at Sumba in Eastern Indonesia Is Prevalent, Diverse and Severe: Implications for Primaquine Therapy against Relapsing Vivax Malaria
por: Satyagraha, Ari Winasti, et al.
Publicado: (2015)

Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia
por: Satyagraha, Ari W., et al.
Publicado: (2016)

Case Series of Primaquine-Induced Haemolytic Events in Controlled Trials with G6PD Screening
por: Kosasih, Ayleen, et al.
Publicado: (2023)

Determining a critical threshold for G6PD activity below which red blood cell response to oxidative stress is poor
por: Swastika, Maria, et al.
Publicado: (2020)

Repeatability and reproducibility of a handheld quantitative G6PD diagnostic
por: Ley, Benedikt, et al.
Publicado: (2022)

Modelling primaquine-induced haemolysis in G6PD deficiency
por: Watson, James, et al.
Publicado: (2017)

A Review of the Current Status of G6PD Deficiency Testing to Guide Radical Cure Treatment for Vivax Malaria
por: Sadhewa, Arkasha, et al.
Publicado: (2023)

Primaquine-induced haemolysis in females heterozygous for G6PD deficiency
por: Chu, Cindy S., et al.
Publicado: (2018)

Barriers to routine G6PD testing prior to treatment with primaquine
por: Ley, Benedikt, et al.
Publicado: (2017)

G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs
por: Bancone, Germana, et al.
Publicado: (2021)

Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells
por: Baird, J. Kevin, et al.
Publicado: (2015)

Association of Impaired Cytochrome P450 2D6 Activity Genotype and Phenotype With Therapeutic Efficacy of Primaquine Treatment for Latent Plasmodium vivax Malaria
por: Baird, J. Kevin, et al.
Publicado: (2018)

G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests
por: Domingo, Gonzalo J, et al.
Publicado: (2013)

G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients
por: Avalos, Sara, et al.
Publicado: (2018)

Review of the interactions between G6PD deficiency and primaquine therapy for malaria control and elimination
por: Howes, Rosalind
Publicado: (2014)

Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria
por: Baird, Kevin
Publicado: (2015)

Safety of primaquine given to people with G6PD deficiency: systematic review of prospective studies
por: Uthman, Olalekan A., et al.
Publicado: (2017)

Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia
por: Lo, Eugenia, et al.
Publicado: (2019)

Point-of-Care Testing for G6PD Deficiency: Opportunities for Screening
por: Anderle, Athena, et al.
Publicado: (2018)

Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria
por: Taylor, Walter R. J., et al.
Publicado: (2021)

Safety of Single-Dose Primaquine in G6PD-Deficient and G6PD-Normal Males in Mali Without Malaria: An Open-Label, Phase 1, Dose-Adjustment Trial
por: Chen, Ingrid, et al.
Publicado: (2018)

Genetic Variation of G6PD and CYP2D6: Clinical Implications on the Use of Primaquine for Elimination of Plasmodium vivax
por: Stewart, Alexandra G. A., et al.
Publicado: (2021)

Primaquine-induced Severe Hemolysis in the Absence of Concomitant Malaria: Effects on G6PD Activity and Renal Function
por: Douglas, Nicholas M., et al.
Publicado: (2023)

Prevalence of G6PD deficiency and G6PD variants amongst the southern Thai population
por: Nuinoon, Manit, et al.
Publicado: (2022)

Performance of the CareStart™ G6PD Deficiency Screening Test, a Point-of-Care Diagnostic for Primaquine Therapy Screening
por: Kim, Saorin, et al.
Publicado: (2011)

Cytochemical flow analysis of intracellular G6PD and aggregate analysis of mosaic G6PD expression
por: Kalnoky, Michael, et al.
Publicado: (2018)

Production and differential activity of recombinant human wild-type G6PD and G6PD(Viangchan)
por: Vengidasan, Lelamekala, et al.
Publicado: (2020)

Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers
por: Rueangweerayut, Ronnatrai, et al.
Publicado: (2017)

Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common
por: White, Nicholas J, et al.
Publicado: (2012)

The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis
por: Chu, Cindy S., et al.
Publicado: (2019)

G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination
por: Han, Kay Thwe, et al.
Publicado: (2021)

Spatial distribution of G6PD deficiency variants across malaria-endemic regions
por: Howes, Rosalind E, et al.
Publicado: (2013)

Genotype-Phenotype Correlation of G6PD Mutations among Central Thai Children with G6PD Deficiency
por: Boonyawat, Boonchai, et al.
Publicado: (2021)

Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms
por: Baird, J. Kevin, et al.
Publicado: (2018)

Prevalence of G6PD Deficiency in Iran
por: Shahjahani, Mohammad, et al.
Publicado: (2013)

Is Hypoglycemia Caused by G6PD Deficiency?
por: Agarwal, Shubham, et al.
Publicado: (2021)

Suitability of Capillary Blood for Quantitative Assessment of G6PD Activity and Performances of G6PD Point-of-Care Tests
por: Bancone, Germana, et al.
Publicado: (2015)

Structural analysis of clinically relevant pathogenic G6PD variants reveals the importance of tetramerization for G6PD activity
por: Cunningham, Anna D, et al.
Publicado: (2017)

Molecular characterization of G6PD mutations reveals the high frequency of G6PD Aures in the Lao Theung population
por: Sanephonasa, Amkha, et al.
Publicado: (2021)

Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania
por: Djigo, Oum Kelthoum Mamadou, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ghcslgosqdltfl0rtr3ibteve6